Industry News
  • Loading News...

Bell Media invests in Hubub

    Bell Media invests in Hubub

Bell Media has made a $5 million investment in Hubub, Inc. Under the terms of the agreement, Bell Media has committed millions more to market Hubub.com and the Hubub mobile

Read Full Article

VC-backed Beyond the Rack secures $10M Facility with SVB

    VC-backed Beyond the Rack secures $10M Facility with SVB

Beyond the Rack (BTR) has recently closed a US $10 million debt and banking facility with Silicon Valley Bank (SVB). “We are delighted to announce this funding from SVB which

Read Full Article

Trulioo secures strategic investment from UST Global

Trulioo, an identity verification company, has received a strategic investment from UST Global, a leading provider of end-to-end IT services and solutions for Global 1000 companies. “As corporations continue to

0 comment Read Full Article

Tuckamore terminates Birch Hill backed going private transaction, secures Orange Capital financing

Tuckamore Capital Management Inc. (TSX: TX) and Triumph Acquisition LP have mutually agreed to terminate the previously announced plan of

0 comment Read Full Article

Spectral shareholders approve Toray and Birch Hill led financing

Spectral Diagnostics Inc. (TSX: SDI; OTC QX: DIAGF) has obtained shareholders approval of its previously announced proposed non-brokered private placement

0 comment Read Full Article

Wellspring Financial closes $3M private placement

Wellspring Acceptance Corporation, operating as Wellspring Financial, a provider of point-of-sale consumer finance solutions, has raised $3 million by way

0 comment Read Full Article

Slyce raises $12M as part of going public RTO transaction

Slyce has raised over $12 million by way of brokered private placement completed by a syndicate of agents led by

0 comment Read Full Article

Transition Therapeutics announces $17M private placement

Transition Therapeutics Inc. (TSX: TTH; NASDAQ: TTHI) intends to complete a US $17 million private placement with Jack W. Schuler,

0 comment Read Full Article

Stem Cell Therapeutics changes name to Trillium Therapeutics

Stem Cell Therapeutics Corp. (TSX: SSS; OTCQX: SCTPF), an immuno-oncology company developing innovative therapies for the treatment of cancer, has

0 comment Read Full Article

Sign Up for Daily Deals and News Update

* = required field

CVCA Events

CVCA on Twitter